Who owns DRUGS MADE IN AMER ACQ II CO?
- Ticker: DMII
- CUSIP Number: g2851k104
Tip: Access positions for across all investors
Analyze quarterly positions in Drugs Made In Amer Acq Ii with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Drugs Made In Amer Acq Ii stock
Who bought or sold DRUGS MADE IN AMER ACQ II CO this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Magnetar Financial | 2.7M | $27M | 0% | Mar 2026 |
|
| MMCAP International Inc. SPC | 2.7M | $27M | 100% | Mar 2026 |
|
| Karpus Investment Management | 2.6M | $26M | 127% | Mar 2026 |
|
| Glazer Capital | 2.3M | $23M | 0% | Mar 2026 |
|
| Healthcare Of Ontario Pension Plan Trust Fund | 2.0M | $20M | 100% | Mar 2026 |
|
| Millennium Management | 2.0M | $20M | 32% | Mar 2026 |
|
| Hudson Bay Capital Management | 2.0M | $20M | 0% | Mar 2026 |
|
| Wolverine Asset Management | 1.8M | $18M | 69% | Mar 2026 |
|
| Tenor Capital Management | 1.5M | $15M | 0% | Mar 2026 |
|
| Polar Securities | 1.5M | $15M | 0% | Mar 2026 |
|
| D. E. Shaw & Co | 1.4M | $14M | 39% | Mar 2026 |
|
| HGC Investment Management | 1.2M | $12M | 0% | Mar 2026 |
|
| CNH Partners | 1.1M | $11M | -3% | Mar 2026 |
|
| Aristeia Capital | 1.1M | $11M | 0% | Mar 2026 |
|
| Vivaldi Asset Management | 1.1M | $11M | -48% | Mar 2026 |
|
| OMERS Administration Corporation | 1.0M | $10M | 0% | Mar 2026 |
|
| Davidson Kempner Capital Management | 1.0M | $10M | 0% | Mar 2026 |
|
| Two Sigma Investments | 887k | $8.8M | 0% | Mar 2026 |
|
| Picton Mahoney Asset Management | 875k | $8.7M | 0% | Mar 2026 |
|
| Moore Capital Management | 750k | $7.5M | 0% | Mar 2026 |
|
| Context Capital Management | 750k | $7.5M | 0% | Mar 2026 |
|
| Ghisallo Capital Management | 750k | $7.5M | 0% | Mar 2026 |
|
| Mercuria Capital Strategies | 750k | $7.5M | 100% | Mar 2026 |
|
| HighTower Advisors | 715k | $7.1M | -9% | Mar 2026 |
|
| Radcliffe Capital Management | 576k | $5.7M | 0% | Mar 2026 |
|
| Heights Capital Management | 519k | $5.2M | 100% | Mar 2026 |
|
| Westchester Capital Management | 500k | $5.0M | 0% | Mar 2026 |
|
| OZ Management | 500k | $5.0M | 0% | Mar 2026 |
|
| HBK Investments | 500k | $5.0M | 0% | Mar 2026 |
|
| BlueCrest Capital Management | 500k | $5.0M | 100% | Mar 2026 |
|
| Sona Asset Management | 500k | $5.0M | 67% | Mar 2026 |
|
| Whitebox Advisors | 450k | $4.5M | 0% | Mar 2026 |
|
| Shaolin Capital Management | 425k | $4.2M | 0% | Mar 2026 |
|
| Wealthspring Capital | 403k | $4.0M | -2% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 395k | $3.9M | 13% | Mar 2026 |
|
| Commonwealth of Pennsylvania | 350k | $3.5M | -12% | Mar 2026 |
|
| Crossingbridge Advisors | 350k | $3.5M | 100% | Mar 2026 |
|
| Lineage Point Capital | 336k | $3.4M | 0% | Mar 2026 |
|
| Rivernorth Capital Management | 300k | $3.0M | 100% | Mar 2026 |
|
| Mint Tower Capital Management B.V. | 250k | $2.5M | 0% | Mar 2026 |
|
| Highbridge Capital Management | 225k | $2.2M | 100% | Mar 2026 |
|
| Jpmorgan Chase & Co | 225k | $2.2M | 100% | Mar 2026 |
|
| Periscope Capital | 225k | $2.2M | -15% | Mar 2026 |
|
| Verition Fund Management | 203k | $2.0M | 1% | Mar 2026 |
|
| Gabelli Securities | 180k | $1.8M | 100% | Mar 2026 |
|
| Gabelli Funds | 161k | $1.6M | 100% | Mar 2026 |
|
| Parallax Volatility Advisers | 134k | $1.3M | 100% | Mar 2026 |
|
| Schonfeld Strategic Advisors | 112k | $1.1M | 100% | Mar 2026 |
|
| DLD Asset Management | 112k | $1.1M | -1% | Mar 2026 |
|
| CSS | 110k | $1.1M | -86% | Mar 2026 |
|
| Toronto-Dominion Bank | 104k | $1.0M | 100% | Mar 2026 |
|
| Centiva Capital | 100k | $998k | 100% | Mar 2026 |
|
| Peak6 | 100k | $997k | 0% | Mar 2026 |
|
| Deltec Asset Management | 50k | $499k | 0% | Mar 2026 |
|
| PenderFund Capital Management | 50k | $496k | 100% | Mar 2026 |
|
| UBS Group | 45k | $446k | 100% | Mar 2026 |
|
| Royal Bank of Canada | 41k | $409k | 100% | Mar 2026 |
|
| Virtu Financial | 40k | $403k | 26% | Mar 2026 |
|
| Abc Arbitrage Sa | 40k | $399k | 0% | Mar 2026 |
|
| Geode Capital Management | 40k | $396k | 48% | Mar 2026 |
|
| Oakmont Partners | 31k | $306k | -17% | Mar 2026 |
|
| Mizuho Securities Usa | 19k | $184k | -91% | Mar 2026 |
|
| Clear Street Group | 15k | $153k | 100% | Mar 2026 |
|
| Limestone Investment Advisors | 12k | $119k | 100% | Mar 2026 |
|
| Logan Stone Capital | 11k | $113k | 100% | Mar 2026 |
|
| Robinson Capital Management | 10k | $100k | 100% | Mar 2026 |
|
| Morgan Stanley | 119.00 | $1.2k | -30% | Mar 2026 |
|
Who sold out of Drugs Made In Amer Acq Ii?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Quarry | Dec 2025 | 100k | $990k |
| Cable Car Capital | Dec 2025 | 100k | $990k |